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Abstract
Background: Whiplash injuries are an important public health problem that is associated with
significant disability and high health care utilization. Recent cohort studies suggest that physician
care may be the most effective treatment for patients with whiplash-associated disorders.
However, these findings have not been tested in a randomized controlled trial. The purpose of this
study is to determine which of physician care or two rehabilitation programs of care is most
effective in improving recovery of patients with recent whiplash associated disorders.
Methods and Design: We designed a pragmatic randomized clinical trial. A total of 444
participants (148 in each of three arms) who reside in Southern Ontario, Canada will be recruited
from a large insurer. We will include individuals who are 18 years of age or older and who are
diagnosed with Grade I or II Whiplash-associated Disorders. Participants will be randomized to
physician-based education and activation or one of two rehabilitation programs of care currently
in use in Ontario. Our primary outcome, self-rated global recovery and all secondary outcomes
(neck pain intensity, whiplash disability, health-related quality of life, depressive symptomatology
and satisfaction with care) will be measured at baseline by a trial coordinator and at 6 weeks, 3, 6,
9 and 12 months follow-up by an interviewer who is blind to the participants' baseline
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Trials 2008, 9:75 http://www.trialsjournal.com/content/9/1/75characteristics and treatment allocation. We will also collect information on general health status,
other injuries, comorbidities, expectation of recovery, work status, pain coping, legal
representation, and co-interventions. The primary intention-to-treat analysis will compare time to
recovery between the three interventions. This trial will have 90% power at an alpha of 0.05 to
detect a 20% difference in the rate of perceived recovery at one year. Secondary analyses will
compare the health outcomes, rate of recurrence and the rate of adverse events between
intervention groups.
Conclusion: The results of this study will provide the public, clinicians and policy makers much
needed evidence on the effectiveness of common approaches used to manage whiplash-associated
disorders.
Trial registration: ClinicalTrials.gov identifier NCT00546806
Background
Whiplash is the most common traffic injury, affecting
83% of people involved in motor vehicle collisions.[1]
The injury leads to "Whiplash-associated Disorders"
(WAD), a clinical syndrome that includes neck pain and
clusters of physical and psychological symptoms.[2,3]
WAD result in a significant burden of pain, disability and
health care utilization.[1,2,4-7] Moreover, WAD may
increase the risk of future health problems. Studies from
Sweden and Saskatchewan suggest that individuals with a
history of whiplash injuries may be more likely than those
without a history of whiplash injuries to suffer from
future episodes of neck pain, headaches, low back pain,
shoulder pain, and sleep disturbances.[1,8-10]
Exorbitant health care costs, increasing disability rates and
uncertainty about the most effective management of WAD
have led governments, insurers and clinicians throughout
the Western world to develop treatment guidelines and
programs of care for the treatment of whiplash inju-
ries.[1,2,11-15] Traditionally, these guidelines have
emphasized the delivery of clinical interventions and
focused less on the environment surrounding the claim
process. However, it is well known that the recovery from
WAD also depends on contextual factors.[1,4,16,17]
A growing body of evidence suggests that the type, inten-
sity and timing of health care delivery are strongly and
independently associated with time to recovery. Specifi-
cally, Côté et al. found that patients who made more than
two visits to general practitioners, more than six visits to
chiropractors, received care from general practitioner and
chiropractors and those who consulted general practition-
ers and specialists within the first month of their injury
took longer to recover than patients who visited general
practitioners once or twice.[4,5] In another cohort, Cas-
sidy et al. investigated the effectiveness of a province-wide
rehabilitation program in Saskatchewan and found that
patients who attended fitness training or a multidiscipli-
nary outpatient rehabilitation program within 120 days of
their injury had slower recovery than those who received
usual community care.[11] Finally, a recent randomized
trial compared "education and advice" by general practi-
tioners to "education and exercises" by physiotherapists
in patients with WAD lasting more than four weeks.[18]
One year after the injury, patients in the general practi-
tioner group reported levels of neck pain and headache
intensity that were lower than those treated by physiother-
apists.[18] Overall, this evidence suggests that the type
and intensity of clinical care strongly influences the prog-
nosis of whiplash injuries.
Despite the efforts of governments and insurers, we still
do not know whether guidelines or programs of care are
effective in improving health outcomes and reducing
costs of patients with WAD. To date, no randomized trials
have investigated the effectiveness of a coordinated and
staged multidisciplinary rehabilitation program aimed at
improving the health outcomes of patients with WAD.
Moreover, it is not known whether rehabilitation pro-
grams are superior to physician-based education and acti-
vation in promoting better health outcomes. Therefore,
there is a need for a pragmatic randomized controlled trial
to investigate which program of care yields the best out-
comes for patients.
Our primary objective is to determine whether education
and activation by a physician is more effective than two
rehabilitation programs of care ("Soft Tissue Injury Care
Model" developed by AVIVA Canada and the "Pre-
approved Framework Guideline for Grade I and II Whip-
lash Associated Disorders" developed by the Financial
Services Commission of Ontario, an arm's length agency
of the Ontario Ministry of Finance) in improving recovery
from WAD.
Our secondary objectives will compare the effectiveness of
the three interventions on reducing neck pain intensity,
reducing whiplash-related disability, improving the
health-related quality of life, reducing depressive symp-Page 2 of 10
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claim durations, and reducing the recurrence rate in
patients with WAD.
Methods
Design
We will conduct a three-arm pragmatic randomized con-
trolled trial (Figure 1).
Source population
Eligible for the study are individuals who: 1) are 18 years
of age or older; 2) reside or work in the Greater Toronto
area, Mississauga, Burlington, Cambridge or Kitchener; 3)
are injured in a traffic collision; 4) make an insurance
claim for physical injury to AVIVA Canada between Febru-
ary 2008 and March 2011.
Study Design: Process of recruitment, randomization to treatment, treatment provision, and outcomes assessmentFigure 1
Study Design: Process of recruitment, randomization to treatment, treatment provision, and outcomes 
assessment.
Identify potential participants with whiplash-
associated disorders (WAD) grade I and II to 
particpate in the trial
Randomize 444 participants
Soft Tissue Injury 
Care Model
n=148
Pre-Approved Framework 
(PAF) 
n=148
Education and Activation 
n=148
Physiotherapy care 
provided according to 
the program
Physiotherapy care 
provided according to 
the program
Care provided by a 
physician
Outcomes assessed at 6 weeks, 3, 6, 9 and 12 months using data collected by a blinded interviewer
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Potential participants will be identified by AVIVA claims
adjusters when policy holders contact AVIVA's claim
center to report an injury. The adjuster will determine
whether the claimant resides or works within the catch-
ment areas of our treatment centers and has sustained a
physical injury during the motor vehicle collision. If both
these criteria are met, she/he will use a standardized script
to invite the claimant to learn more about the trial. Claim-
ants who are interested will be referred immediately to the
University Health Network (UHN) trial coordinator who
will arrange an appointment at the nearest study clinic to
assess the claimant's eligibility for the trial.
Inclusion and exclusion criteria
All potential participants will be assessed by a trial coordi-
nator to determine whether they meet the inclusion/
exclusion criteria (Table 1). The assessment will include a
history and physical examination and, if clinically indi-
cated, diagnostic imaging.
Randomization to treatment groups
Participants will be randomly allocated to one of the three
intervention arms after they complete the consent process
and answer the baseline questionnaire. If passengers from
the same motor vehicle agree to participate, they will be
randomized to the same treatment arm to minimize con-
tamination and potentially minimize cross-over between
treatment arms. Therefore, our unit of randomization is
the motor vehicle. Central randomization was performed
by the study biostatistician using statistical package,
NQuery Advisor® 7.0.[19] To minimize the risk of unbal-
anced treatment assignment related to patient heterogene-
ity, we used block randomization which was stratified by
clinical centre. The size of the blocks was randomly deter-
mined and vary between three, six, nine and 12 partici-
pants. The biostatistician provided the trial coordinators
with a series of sealed opaque envelopes sequentially
numbered by clinical centre. The study biostatistician is
not involved in the selection of participants.
Interventions
Participants randomly assigned to the rehabilitation pro-
grams of care will be treated at one of three University
Health Network Rehabilitation Solution clinics located at
the Toronto Western Hospital in Toronto, and at satellite
clinics in Mississauga and Cambridge, which are areas
outside of Toronto. All services will be provided by regu-
lated health professionals including physiotherapists,
kinesiologists, occupational therapists and massage thera-
pists. Participants allocated to the physician-based "Edu-
cation and Activation" arm will be referred to family
physicians located at Toronto Western Hospital, the Reha-
bilitation Solutions clinic in Cambridge, and a private
clinic in Mississauga. Health care professionals will be
assigned to one treatment arm only. As recommended by
the Financial Services Commission of Ontario, all partici-
pants will receive a "Getting the Facts about Whiplash"
brochure. The brochure includes basic information about
whiplash.[20]
Soft Tissue Injury Care Model
The "Soft Tissue Injury Care Model" is a staged multidisci-
plinary rehabilitation program of care developed by
AVIVA Canada. The model aims to reduce the administra-
tive burden related to the claim process and facilitate
access to timely health care. Participants randomized to
the "Soft Tissue Injury Care Model" will obtain assistance
from the clinic staff to complete the insurance forms nec-
essary to initiate the claim. The program will be led by a
physiotherapist and includes three integrated and sequen-
tial rehabilitation components: 1) Acute-subacute Phase;
2) Multidisciplinary Evaluation and 3) Interdisciplinary
Rehabilitation.
Table 1: Inclusion and exclusion criteria
Inclusion criteria
Diagnosed with Grade I or Grade II WAD
Report an average neck pain since the accident of at least 3 on a 0–10 "Numerical Rating Scale" (NRS)
Able to give written informed consent and complete interviews in English 
(translators will be available to assist the participant if she/he experiences difficulty understanding specific items on the questionnaire)
Make an insurance claim for physical injury and enroll in trial within 21 days of the traffic collision
Exclusion criteria
Fracture/dislocation of the spine or any major bone
Head trauma associated with loss of consciousness
Past whiplash or work-related neck injury within the year prior to their current injury
Active systemic diseases (cancer, inflammatory arthritis, disorders of central nervous system)
Previous neck surgery
Received treatment from a physiotherapist or chiropractor for neck pain in the three months preceding the motor vehicle collision
Individuals who do not reside or work in the Greater Toronto, Mississauga, Burlington, Cambridge or Kitchener areasPage 4 of 10
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During the first six weeks post-injury, care will be deliv-
ered by physiotherapists, and if necessary kinesiologists
and massage therapists. The care consists of: 1) reassur-
ance; 2) education; 3) home exercises, 4) physiotherapy
modalities to reduce pain and 5) massage therapy. A max-
imum of nine treatments (including massage therapy)
during the first three weeks post-collision and an addi-
tional eight sessions (including massage therapy) between
the third and sixth week post-collision will be allowed.
The type and frequency of treatment will be prescribed by
the physiotherapist based on her/his assessment. During
this phase, the physiotherapist may recommend an "in-
home" or "job site" functional assessment. Finally, the
physiotherapist will refer the participant to a Multidisci-
plinary Evaluation if she/he is not progressing as expected.
Multidisciplinary evaluation
Patients who require treatment beyond the acute-suba-
cute phase will be referred for a multidisciplinary evalua-
tion. The evaluation will be conducted by an independent
team that may include a physiotherapist, physician, occu-
pational therapist, psychologist, and kinesiologist. The
purpose of the multidisciplinary evaluation is to identify
barriers to recovery and recommend the appropriate treat-
ment through interdisciplinary rehabilitation program.
Interdisciplinary rehabilitation
The interdisciplinary rehabilitation program has three
specific goals: 1) overcome psychosocial barriers to return
to function; 2) physical restoration; and 3) functional res-
toration. The program will include up to five weeks of
daily intervention (each session can last up to 5.5 hours).
The frequency, duration and type of care will be deter-
mined by the interdisciplinary team. The team may
include a physician, physiotherapist, occupational thera-
pist, and a psychologist. Moreover, the following individ-
uals may be invited to join the team: 1) insurance claims
advisor; 2) kinesiologist; 3) vocational counselor; 4)
employer; 5) ergonomist; and 6) cognitive behavioral
therapist. If necessary, the interdisciplinary rehabilitation
program will include a jobsite assessment. The services
provided during interdisciplinary rehabilitation can
include: 1) education; 2) reassurance; 3) goal setting and
advice on self-management; 4) psychological counseling
and stress management; 5) relaxation therapy, psycho-
therapy and family counseling; 6) cognitive behavioral
therapy; 7) instruction on pain management techniques;
and 8) strength, endurance, flexibility or cardiovascular
exercises.
Pre-approved framework guideline for Grade I and II 
Whiplash Associated Disorders (PAF)
The PAF is a clinical management guideline that focuses
on the provision of interventions to manage pain and dis-
ability through functional restoration.[20] Its use is man-
dated in Ontario for patients with Grade I and II
WAD.[20] The treatment will be provided under the
supervision of a physiotherapist and includes: 1) reassur-
ance; 2) education; 3) home exercises, and 4) encourage-
ment to resume normal activities of daily living.
Additionally, the physiotherapist may prescribe the fol-
lowing interventions: 1) exercise and functional activities;
2) mobilization and manipulation; 3) pain management
modalities (including massage therapy); and 4) coping
skills education. The frequency and number of visits is
based on the clinical judgment of the physiotherapist but
cannot exceed 10 visits within the first three weeks and
nine visits three to six weeks post-collision.
Participants with significant functional limitations will be
eligible for a functional assessment of their home, work or
school environment. Based on the assessment, occupa-
tional therapists will develop an intervention that may
include: 1) recommendation to use aids or devices; 2)
minor modifications at the work, home, or school envi-
ronment; 3) instructions on adaptive strategies or alter-
nate approaches to fulfill functional tasks; and 4) specific
functional activities to increase tolerance.
Participants who report significant improvement in the
first six weeks of care, but who have not recovered, can
receive up to four additional treatments over a two-week
period. Participants who have not recovered will be re-
evaluated and a new plan of management will be devel-
oped by the physiotherapist in charge of the care.
Physician-based education and activation
The education and activation intervention program is
designed to promote self-care and early return to normal
activities of daily living. Participants randomized to edu-
cation and activation will be under the care of a family
physician.
Initial visit
The intervention includes reassurance, education about
the favorable prognosis of WAD, encouragement to
resume activities of daily living, recommendation to do
home exercises (stretching) and, if indicated, prescribe
pain relief modalities (heat/ice, acetaminophen or a Cox-
2 selective non-steroidal anti-inflammatory drug (NSAID)
or non-selective NSAID with or without gastroprotec-
tion). At the end of the initial visit, the physician will
determine whether a follow-up appointment is necessary
or if the participant should be discharged. The participant
will be informed to contact the physician should their
complaint persist or worsen.Page 5 of 10
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If follow-up visits are necessary, the participant will be re-
assessed and the intervention described above will be
repeated and adapted to the participant's status. Partici-
pants who have not recovered six weeks after the injury or
have improved but require more care will be referred for a
multidisciplinary evaluation and enter the interdiscipli-
nary rehabilitation (described above under Soft Tissue
Injury Care Model).
Data collection and follow-up
Table 2 summarizes the data to be collected during the
trial. We will follow-up participants at six weeks, and
three, six, nine and 12 months post-injury. All follow-up
interviews will be conducted by a research assistant either
in person at the study clinic or by telephone. The study
research assistant will be blind to the treatment allocation
and to the baseline characteristics of participants. How-
ever, because most outcomes are self-reported by the par-
ticipants, the research assistant will not be blind to their
outcomes status.
Outcomes
Primary outcomes
Time to recovery
Our primary outcome is time to recovery measured by the
global self-perceived recovery question. The global per-
ceived recovery question is a reliable, valid and responsive
measure of health status in patients with musculoskeletal
disorders.[21] This ordinal transition scale has been used
in previous randomized trials and cohort studies of neck
pain.[11,22,23] In patients with WAD, we have previously
reported that perceived recovery is consistently associated
with less neck pain, better physical functioning and fewer
depressive symptoms.[11]
At each follow-up interview, participants will be asked:
"How well do you feel you are recovering from your inju-
Table 2: Measures used at baseline and follow-up interviews
Measures Baseline 6 Weeks 3 Months 6 Months 9 Months 12 Months
Accident information x
Past history of neck pain and whiplash x
Numerical rating scale x x x x x x
Health care after accident x
Comorbidity questionnaire x
Acute 36-item short-form health survey (V2) x x x x x x
Work status x x x x x x
Expectation of recovery x x x x x x
Whiplash disability questionnaire x x x x x x
Center for epidemiological studies-depression scale (CES-D) x x x x x x
Vanderbilt pain management inventory x x x
Health state question x x x x x x
Socio-demographic characteristics x
Whether a lawyer or paralegal is involved in the claim x x x x x x
Global perceived recovery question x x x x x x
Satisfaction with care and treatment outcome x x x x x
Co-interventions x x x x xPage 6 of 10
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lowing choices: 1) completely better; 2) much improved;
3) slightly improved; 4) no change; 5) slightly worse; 6)
much worse and 7) worse than ever. Participants who
respond to be "completely recovered" or "much
improved" will be considered recovered. Time to recovery
will be measured as the number of days between the date
of injury and the first follow-up date at which a partici-
pant reports to be "completely recovered" or "much
improved".
Secondary outcomes
Neck pain intensity
Neck pain intensity will be measured at baseline and at
each follow-up with the 11-point numerical rating scale
(NRS). The NRS is a global measure of pain intensity
anchored by two extremes of pain intensity ranging from
0 (referring to "No pain") to 10 (referring to "Pain as bad
as it could be"). The NRS has good short-term test-retest
reliability with correlation coefficient ranging from 0.95–
0.99 when re-administered within 24 hours.[24] The NRS
has good construct validity and can distinguish between
various levels of pain in subjects with chronic post-opera-
tive pain.[24,25] It correlates well with other instruments
used to measure pain.
Whiplash disability
Disability will be measured with the Whiplash Disability
Questionnaire (WDQ).[26] The WDQ is a 13-item modi-
fied version of the Neck Disability Index. It includes 13
Likert scales scored from 0 to 10 with higher global scores
indicating more disability. The instrument has adequate
face validity, discriminate validity and good internal con-
sistency (Cronbach's alpha = 0.96). [26,27] Pinfold et al.
(2006)[26] reported that the WDQ has no substantial
ceiling or floor effect. In patients with chronic stable
symptoms, the WDQ has excellent short-term (24 hours)
and medium-term (one month) reproducibility (Intra-
correlation coefficient = 0.90, and 0.86, respectively).[28]
The WDQ is a responsive scale with a minimal detectable
change of 15 points.[28]
Health-related quality of life (H-RQoL)
We will use the Medical Outcomes Study Short-Form
Health Survey version two (SF-36) to measure health-
related quality of life. The SF-36 has 36 items which meas-
ure the H-RQoL of a subject. Two summary scores can be
computed: the physical component score and the mental
component score. There are eight individual scales: phys-
ical functioning, role physical, bodily pain, general
health, vitality, social functioning, role emotional and
mental health. The questionnaire has been shown to have
excellent reliability demonstrated with internal consist-
ency and test-retest methods. The SF-36 is a valid and reli-
able measure for clinical and general populations with a
reported intra-class correlation coefficient of 0.85. [29-31]
Further, in a study of injured workers with musculoskele-
tal conditions it was shown to be the instrument that is
the most responsive to change.[32]
Depressive symptomatology
Depressive symptomatology in the previous week will be
measured with the Center for Epidemiological Studies-
Depression Scale (CES-D). The CES-D is a widely used 20-
item self-report scale designed to measure current level of
depressive symptomatology in population-based epide-
miologic research.[3,33,34] It has good test-retest reliabil-
ity and internal consistency and possesses good factorial
and discriminant validity.[33,35-42] The CES-D is scored
from 0 to 60 with higher scores indicating greater depres-
sive symptomatology.[33,36]
Satisfaction with care and satisfaction with treatment
Two global questions will be used to quantify satisfaction
with care and satisfaction with treatment outcome. Satis-
faction with care will be measured by asking participants
the following question: "All things considered, how satis-
fied are you with the care you received?" Similarly, satis-
faction with treatment outcome will be measured by
asking "All things considered, how satisfied are you with
the results of your treatment?".[43,44] Participants will be
asked to rate their satisfaction on a Likert scale ranging
from 1 = extremely satisfied to 7 = extremely dissatisfied.
Time on insurance benefit
We will measure the number of days between the date of
injury and the date corresponding to the closure of the
insurance claim. Claim closure corresponds to the end of
treatment, the attainment of maximal medical improve-
ment, the termination of income replacement benefits or
the date of payment of the last outstanding bill incurred
by the claimant (e.g., eyewear). Claim closure dates will
be provided by AVIVA Canada. We have previously vali-
dated time on benefit as a marker of time to health recov-
ery in a population of whiplash patients from
Saskatchewan and found that claimants who close their
claims have significantly lower levels of neck pain, better
physical functioning and no depression compared to
claimants who have not closed their claim.[16]
Recurrence
A recurrence will occur when a participant reports to have
recovered, but reports at any subsequent follow-up on the
self-perceived recovery question to be: 1) slightly
improved; 2) unchanged; 3) slightly worse; 4) much
worse, or 5) worse than ever.
Co-interventions
We will measure co-interventions by asking participants
to self-report the type health care provider consultedPage 7 of 10
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tions. Finally, we will ask participants if they have used
medications for their whiplash injuries.
Statistical Issues
Sample size
Our sample size was selected to detect a difference of 20%
in the rate of recovery at one year using a log rank test, a
power of 90% and a two-tail significance level of 0.05.[19]
Based on these parameters, we need 114 participants per
group. Assuming a 30% loss-to follow-up per arm we aim
to enroll a total of 444 participants (148 per intervention
arm).
It is common for vehicles involved in traffic collisions to
have multiple passengers. Early in our trial, we observed
that some participants enrolled in the study had a spouse
or relative with them in the car at the time of the collision
that was also eligible for the trial. To prevent contamina-
tion bias and promote treatment compliance, we decided
to change the randomization unit from the individual to
the motor vehicle. Consequently, all passengers from the
same vehicle are randomized to the same study arm. We
have observed that less than 5% of vehicles have multiple
passengers. Therefore, our original sample size of 444 par-
ticipants remains valid.
Statistical analysis
Our primary analysis focuses on studying treatment pol-
icy and therefore will be conducted according to the inten-
tion-to-treat principle, that is, participants will be
analyzed according to their randomized intervention
group whether or not they received the intervention.
However, we are also interested in understanding the
impact of treatment self-selection and protocol deviations
on the primary and secondary outcomes. To achieve this
goal, we will also analyze the trial using the "as treated"
(participants will be analyzed according to the treatment
they received) and "per-protocol" (the analysis will be
restricted to participants who were compliant with the
treatment protocol) approaches.
Primary outcomes: self-perceived recovery
Our primary analysis will compare the time to recovery
across intervention arms using the Kaplan-Meier method.
We will report the median time to recovery and 95% con-
fidence interval (CI).[45] We will use mixed-effect Cox
proportional hazards model to measure the effectiveness
of the physician-based education and activation interven-
tion and of the Soft Tissue Injury Care Model relative to
the PAF. [45-49] Effectiveness will be reported as the Haz-
ard Rate Ratio (HRR) and 95% confidence interval (CI).
Participant characteristics that vary between the three
interventions at baseline will be included in a multivaria-
ble Cox proportional hazards model to control for their
confounding effect. Covariates added to the crude Cox
Model that change any of intervention regression coeffi-
cients by 10% percent or more will be retained as con-
founders in the adjusted model.[50] The observations of
participants who drop out of the study before they report
to have recovered will be censored on the date of their last
completed follow-up interview. No imputation methods
will be used to deal with missing outcomes.
Secondary outcomes
To analyze the continuous secondary outcomes (neck
pain intensity, whiplash disability, health-related quality
of life, depressive symptomatology, satisfaction with
care), we will first compute the intervention-specific
mean, standard deviation and median at each follow-up
interval. Second, we will build ordinary least-square
(OLS) models using generalized estimating equation
(GEE) to account for the autocorrelation present in the
outcomes.[51] Third, we will test whether the interven-
tion effects are constant throughout the follow-up peri-
ods.[51] Fourth, we will test whether imbalances in the
distribution of the baseline covariates confound the inter-
vention effects. Covariates added to the crude linear
model that change any of intervention regression coeffi-
cients by 10% percent or more will be retained as con-
founders in the adjusted models.[50] The intervention
effects will be reported as the mean differences and 95%
for each follow-up interval.
We will analyze time to claim closure using the Kaplan-
Meier method and the Cox proportional hazards model as
described above. Effectiveness will be reported as the HRR
and 95% CI.
To analyze the recurrence rate, we will first compute the
intervention-specific incidence (95% CI) of recurrence.
Second, we will use Poisson regression and GEE to
account for the autocorrelation present in the report of
self-perceived recovery.[51] In the Poisson model, the
number of recurrences will be used as the outcome varia-
ble. Third, we will test whether imbalances in the distribu-
tion of the baseline covariates confound the intervention
effects. Covariates added to the crude Poisson model that
change any of intervention regression coefficients by 10%
percent or more will be retained as confounders in the
models.[50] We will present the intervention effects as rel-
ative risks (RR) and 95% CI.
Pilot study
We conducted a pilot study from February 1 – 25, 2008.
The purpose of the pilot study was to test the feasibility
and implementation of the trial. Specifically, we aimed to:
1) determine the referral rate from AVIVA Canada; 2)
determine the participation rate; 3) test the administra-
tion of the baseline questionnaire; 4) ensure that thePage 8 of 10
(page number not for citation purposes)
Trials 2008, 9:75 http://www.trialsjournal.com/content/9/1/75interventions can be delivered in a timely fashion and
according to the protocol and 6) determine the 6- week
follow-up rate.
The trial coordinators received 41 referrals during the
pilot study for a referral rate of 1.6 calls per day. Of those,
36 were eligible and 12 consented to participate (partici-
pation rate = 33.3%). Our baseline and follow-up ques-
tionnaires were well received by participants. The six week
follow-up rate was 58.3% (7/12). One participant
dropped out of the study to receive care at another clinic
and four participants could not be reached to complete
the follow-up interview. The interventions were delivered
without any difficulties.
Protection of human subjects and assessment of safety
Protection of human subjects
The study protocol was approved by the University Health
Network Research Ethics Board (07-0623-A).
Adverse events
We will measure the presence of adverse events that may
be associated with the treatments at each follow-up inter-
view. We defined adverse events as an unintended sign or
symptom of the intervention. These include: increase in
neck pain, stiffness, radiating pain/discomfort in arms,
arm weakness, leg weakness, feeling tired, headache, diz-
ziness, depression, anxiety or other physical discomfort.
We will compute the intervention-specific incidence (95%
CI) of each adverse event listed above. The intervention-
specific cumulative number of visits will be used as the
denominator. Any adverse event that is life-threatening or
associated with significant disability will be reported to
the University Health Network Research Ethics Board.
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